NEW YORK (GenomeWeb News) – Circulating tumor cell diagnostics developer Epic Sciences has appointed Murali Prahalad to be president and CEO.

Prahalad formerly held multiple posts at Life Technologies, and most recently he was VP of corporate strategies. In that role, he helped shape investment priorities across Life Tech’s research tools, clinical diagnostics, and applied markets portfolios, said Epic in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.